R-Tech Ueno, Ltd.
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- Private, Subsidiary
- Established
- 1989-01-01
- Employees
- 80
- Market Cap
- -
- Website
- https://rtechueno.com
Clinical Trials
8
Active:0
Completed:1
Trial Phases
3 Phases
Phase 1:1
Phase 2:4
Phase 3:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)β’ Click on a phase to view related trials
Phase 2
4 (50.0%)Phase 3
3 (37.5%)Phase 1
1 (12.5%)A Phase 1/2, RU-101 Ophthalmic Solution in Patients With Severe Dry Eye
Phase 1
Completed
- Conditions
- Dry Eye
- First Posted Date
- 2013-05-01
- Last Posted Date
- 2019-09-11
- Lead Sponsor
- R-Tech Ueno, Ltd.
- Target Recruit Count
- 104
- Registration Number
- NCT01843894
- Locations
- πΊπΈ
Virginia Eye Consultants, Norfolk, Virginia, United States
Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa
- First Posted Date
- 2013-02-08
- Last Posted Date
- 2016-01-29
- Lead Sponsor
- R-Tech Ueno, Ltd.
- Target Recruit Count
- 202
- Registration Number
- NCT01786395
News
No news found